Combined oral contraceptives show clear differences in effect on the tissue
factor-initiated coagulation test of activated protein C resistance, which
is dependent on the presence and dosage of levonorgestrel. Multiphasic lev
onorgestrol oral contraceptives differ from monophasic contraceptives and r
esemble third-generation contraceptives.